Accurate pathological diagnosis is crucial for optimal management of patients with cancer.
For the approximately 100 known tumour types of the central nervous system, standardization …

Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable
heterogeneity. We have recently identified recurrent H3F3A mutations affecting two …

Activation of the aryl hydrocarbon receptor (AHR) by environmental xenobiotic toxic chemicals,
for instance 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), has been implicated in a variety …

Purpose: The CD133 antigen has been identified as a putative stem cell marker in normal
and malignant brain tissues. In gliomas, it is used to enrich a subpopulation of highly …

Two recurrent mutations, K27M and G34R/V, within histone variant H3.3 were recently identified
in ∼50% of pHGGs. Both mutations define clinically and biologically distinct subgroups …

Defensins are endogenous antimicrobial peptides that protect the intestinal mucosa against
bacterial invasion. It has been suggested that deficient defensin expression may underlie …

The molecular pathogenesis of pediatric astrocytomas is still poorly understood. To further
understand the genetic abnormalities associated with these tumors, we performed a genome-…

Atypical teratoid/rhabdoid tumor (ATRT) is one of the most common brain tumors in infants.
Although the prognosis of ATRT patients is poor, some patients respond favorably to current …

Here we show that glioblastoma express high levels of branched-chain amino acid transaminase
1 (BCAT1), the enzyme that initiates the catabolism of branched-chain amino acids (…

Epigenetic alterations, that is, disruption of DNA methylation and chromatin architecture, are
now acknowledged as a universal feature of tumorigenesis 1 . Medulloblastoma, a clinically …